The PP2A regulator IER5L supports prostate cancer progression

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
The PP2A regulator IER5L supports prostate cancer progression ; volume:15 ; number:7 ; day:18 ; month:7 ; year:2024 ; pages:1-11 ; date:7.2024
Cell death & disease ; 15, Heft 7 (18.7.2024), 1-11, 7.2024

Creator
Crespo, Jana R.
Martín-Martín, Natalia
Garcia-Longarte, Saioa
Corres-Mendizabal, Jon
Carlevaris, Onintza
Astobiza, Ianire
Zabala-Letona, Amaia
Guiu, Marc
Azkargorta, Mikel
Gonzalez-Lopez, Monika
Macías-Cámara, Nuria
Doan, Phuong
Elortza, Félix
Mendizabal, Isabel
Westermack, Jukka
Gomis, Roger R.
Ercilla, Amaia
Carracedo, Arkaitz
Contributor
SpringerLink (Online service)

DOI
10.1038/s41419-024-06907-z
URN
urn:nbn:de:101:1-2410080817159.977675790178
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Crespo, Jana R.
  • Martín-Martín, Natalia
  • Garcia-Longarte, Saioa
  • Corres-Mendizabal, Jon
  • Carlevaris, Onintza
  • Astobiza, Ianire
  • Zabala-Letona, Amaia
  • Guiu, Marc
  • Azkargorta, Mikel
  • Gonzalez-Lopez, Monika
  • Macías-Cámara, Nuria
  • Doan, Phuong
  • Elortza, Félix
  • Mendizabal, Isabel
  • Westermack, Jukka
  • Gomis, Roger R.
  • Ercilla, Amaia
  • Carracedo, Arkaitz
  • SpringerLink (Online service)

Other Objects (12)

Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression

Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression

Cryo-EM structures of PP2A:B55–FAM122A and PP2A:B55–ARPP19

Cryo-EM structures of PP2A:B55–FAM122A and PP2A:B55–ARPP19

PP2A and tumor radiotherapy

PP2A and tumor radiotherapy

Rac1b supports ligand-independent androgen receptor activation in prostate cancer progression

Rac1b supports ligand-independent androgen receptor activation in prostate cancer progression

The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer

The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer

PRG-1 regulates cell adhesion via PP2A/β1-integrin [PP2A-beta1-integrin] signaling

Hochschulschrift

PRG-1 regulates cell adhesion via PP2A/β1-integrin [PP2A-beta1-integrin] signaling

Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer progression

Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer progression

Author Correction: Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression

Author Correction: Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression

Chemogenetic profiling reveals PP2A‐independent cytotoxicity of proposed PP2A activators iHAP1 and DT‐061

Chemogenetic profiling reveals PP2A‐independent cytotoxicity of proposed PP2A activators iHAP1 and DT‐061

FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs

FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs

Epigenetic Regulation in Prostate Cancer Progression

Epigenetic Regulation in Prostate Cancer Progression

Methylation-regulated decommissioning of multimeric PP2A complexes

Methylation-regulated decommissioning of multimeric PP2A complexes

Related objects